Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H22O2 |
Molecular Weight | 294.3875 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)C=CC3=C4CCC(=O)C=C4CC[C@@]23[H]
InChI
InChIKey=GVDMJXQHPUYPHP-FYQPLNBISA-N
InChI=1S/C20H22O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,8,10,12,17-18,22H,4-7,9,11H2,2H3/t17-,18+,19+,20+/m1/s1
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL208 Sources: https://www.ncbi.nlm.nih.gov/pubmed/527342 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | OGYLINE Approved UseUnknown |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
G03AC07
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
||
|
WHO-VATC |
QG03AC07
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
||
|
NCI_THESAURUS |
C483
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
101105
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | |||
|
100000083618
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | |||
|
7519
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | RxNorm | ||
|
DB13563
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | |||
|
89386PYU9O
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | |||
|
m8064
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | Merck Index | ||
|
13313
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | |||
|
848-21-5
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | |||
|
2373
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | |||
|
C90949
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | |||
|
DTXSID30878491
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | |||
|
3205
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | |||
|
212-698-6
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | |||
|
NORGESTRIENONE
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | |||
|
SUB09372MIG
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | |||
|
D009645
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY | |||
|
CHEMBL1908319
Created by
admin on Sat Dec 16 15:53:33 GMT 2023 , Edited by admin on Sat Dec 16 15:53:33 GMT 2023
|
PRIMARY |
ACTIVE MOIETY